| 1 |
35070055 | Acarbose is again on the stage. | 2022 Jan 15 |
3 |
| 2 |
35558742 | Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China. | 2022 |
3 |
| 3 |
33449919 | The role of GLP-1 in the postprandial effects of acarbose in type 2 diabetes. | 2021 Mar |
5 |
| 4 |
33269063 | Factors associated with improvement in waist-to-height ratio among newly diagnosed type 2 diabetes patients treated with acarbose or metformin: A randomized clinical trial study. | 2020 Nov 15 |
2 |
| 5 |
27717194 | Associations between changes in glucagon-like peptide-1 and bodyweight reduction in patients receiving acarbose or metformin treatment. | 2017 Aug |
5 |
| 6 |
26331290 | Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels. | 2016 Jul |
2 |
| 7 |
25685364 | Acarbose, lente carbohydrate, and prebiotics promote metabolic health and longevity by stimulating intestinal production of GLP-1. | 2015 |
2 |
| 8 |
22983428 | Role of intestinal peptides and the autonomic nervous system in postprandial hypotension in patients with multiple system atrophy. | 2013 Feb |
1 |
| 9 |
23642288 | Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report. | 2013 May 4 |
3 |
| 10 |
11891017 | Glucagon-like peptide-1 response to acarbose in elderly type 2 diabetic subjects. | 2002 May |
2 |
| 11 |
12190996 | The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. | 2002 Sep |
2 |
| 12 |
11383230 | Reactive hypoglycaemia due to late dumping syndrome: successful treatment with acarbose. | 2001 Feb 10 |
1 |
| 13 |
11518688 | Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release. | 2001 Sep |
4 |
| 14 |
9507911 | Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. | 1998 Feb |
1 |